 Long-term observation intravesical metaphylaxis mitomycin patients superficial bladder tumors transurethral resection superficial bladder tumor patients chemoprophylaxis mitomycin period years percent recurrent disease metaphylaxis patients recurrence-free instillation therapy average months period percent patients recurrences forty-four months instillation majority patients recurrent tumors recurrent tumor instillation therapy patients percent recurrence-free observation period twelve fifty-four months instillation therapy conclusion average observation period months percent patients study recurrences